InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Poradosu Enrique, Autre. Director active across 1 company, notably Nuvectis Pharma, Inc.. Aggregated, 10 reports have been logged. Split: 5 buys · 0 sell. Total volume traded: €34k. Activity tracked since 4 February 2022. The latest transaction was filed on 6 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Poradosu Enrique is Autre and is linked to Nuvectis Pharma, Inc., where the listed role is Chief Science & Business Off. The record shows 10 filings in total, and across the 10 sampled filings, the transactions are buys for EUR 34073, with no sales, between 2022-02-08 and 2026-01-09. The modal transaction nature is Attribution.